# LetsGetChecked

> LetsGetChecked connects home sample collection with laboratory testing, clinical support, genomic services and access to treatment. Founded by Peter Foley in Dublin, it serves consumers and healthcare organizations across the US, UK and Europe and now operates as part of Fuze Health.

- **Founded:** 2014
- **Headquarters:** Dublin, Ireland; Fairfield, United States
- **Founders:** Peter Foley (Founder; former CEO)
- **Products:** At-home health tests, Simple 2, Health plan and employer programs, Veritas genomics, ImPress
- **Notable:** Reported over US$1 billion valuation following the June 2021 Series D., Received FDA De Novo authorization for Simple 2 on November 15, 2023., ImPress won a 2024 Red Dot Product Design award.

## Products & services

- **At-home health tests** — Self-collection kits for sexual health, cholesterol, thyroid function, hormones and other health indicators, followed by laboratory analysis and clinical support.
- **Simple 2** — FDA-authorized home sample collection system for chlamydia and gonorrhea testing in adults 18 and older, using urine or vaginal swabs.
- **Health plan and employer programs** — Configured screening, member engagement, biometric and virtual-care programs for organizations.
- **Veritas genomics** — Whole-genome sequencing and clinical genetic services added through the 2022 Veritas acquisitions.
- **ImPress** — Single-use capillary blood lancing device cleared for healthcare professional use; the 2025 clearance excludes at-home collection and lay users.
- **Hereditary cancer solution** — Provider-focused multigene panels, in-house genetic counseling and a collaboration portal, launched April 2025.
- **Digital pharmacy access** — Pharmacy technology and medication fulfillment integrated through Truepill, now within Fuze Health.
- **Onclarity HPV home screening** — Home self-collection program announced with Waters Corporation in August 2026, using the BD Onclarity HPV Assay to detect 14 high-risk HPV genotypes.

## Achievements

- Reported over US$1 billion valuation following the June 2021 Series D.
- Received FDA De Novo authorization for Simple 2 on November 15, 2023.
- ImPress won a 2024 Red Dot Product Design award.
- ImPress received FDA 510(k) clearance on January 13, 2025 for professional use.
- Current company pages report more than 15 million tests and more than 5,000 organizations served.

## Latest updates

- **2026-08** — Announced a Waters Corporation partnership to offer Onclarity HPV home self-collection and laboratory testing.
- **2025-09** — Veritas Genetics announced the acquisition of qGenomics, extending carrier screening and rare disease diagnostics.
- **2025-05** — Fuze Health launched from the combination of LetsGetChecked and Truepill, with Alto joining the group.
- **2025-04** — Launched a provider-focused hereditary cancer testing solution.
- **2025-02** — Announced FDA clearance of the ImPress lancing device for professional use.
- **2025-01** — CB Insights records a US$165 million Series F; investors were not disclosed in that record.

## Links

- Website: https://www.letsgetchecked.com/
- LinkedIn: https://www.linkedin.com/company/letsgetchecked/
- Twitter/X: https://twitter.com/letsgetchecked
- Instagram: https://www.instagram.com/letsgetchecked/
- Facebook: https://www.facebook.com/Letsgetchecked/

---

Profile page: https://yespress.io/letsgetchecked
Published by YesPress — https://yespress.io
Last updated: 2026-10-16